This is being shorted heavily Buy price dropping continuously |
The usual mug punters like JBCo and fonzi desperately trying to ramp on lse |
Not really |
Delayed sells now flying in |
The RNS was a positive update, |
Increased short looks like it's screwed now |
Wnt let me close why |
Looks like you're underwater already |
Check out Tim McCarthys track record with failed Alizyme (and other failures) where he was FC then CEO, and made all the right positive noises in presentations. Three drugs in trials and none passed, but was promising deals right up until the end. Alizyme went into administration, taking shareholders money with it.
Lemmings and mushrooms only. |
Global Attending both meetings gave the ImmuPharma team the opportunity to continue positive discussions with a number of global BioPharma companies, that have already expressed an interest in P140 and its unique approach to treating autoimmune diseases. |
I've shorted brilliant |
 Told ya....CIRCUS.
And now they have had to try to clarify things here following that podcast:
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, notes the recent movements in its share price.
As announced on 9 January 2025, the Company has made innovative groundbreaking advancements in its preclinical research program focused on P140 and the pathogenesis of autoimmune diseases. This new discovery, conducted by the Company's R&D subsidiary ImmuPharma Biotech, has yielded data that provides novel insights into autoimmune disease mechanisms. Through this research, the Company is making a significant step towards personalised medicine in SLE and other autoimmune diseases.
(Link:
The ImmuPharma team also attended the JP Morgan and Biotech Showcase healthcare conferences earlier this month.
Attending both meetings gave the ImmuPharma team the opportunity to continue positive discussions with a number of global BioPharma companies, that have already expressed an interest in P140 and its unique approach to treating autoimmune diseases.
ImmuPharma is not aware of any further material commercial or operational reason for the significant share price movements, however, the Company will continue to update the market on developments, both commercially and scientifically, when appropriate, over the next period.
So they have clarified what they can, except they haven't clarified alot.
Wish I knew if they had the NEXT BIG THING that they say noone else has |
Yea haha.
Rarely does taking your initial cap back and keeping free shares pay in uk little ones. But certainly worth the go here |
That's only with out news lol, with news£110.38lol |
Maker will make a stack with stepped lots rapidly rising it. Has liquidity to do it |
Not even half a point between us on that one. 11.75/12.7 I had it at |
11,38 next stop |
I think it doubles from there pretty fast in market terms. 9s no issue now |
A breakout at recent high, mid,will be very very extreme vertical |
They were running on fumes before this great run so I can't believe there isn't a placing in the works.
Good to see a bit of life in a few AIM dogs recently.
Well done to anyone making some money. |
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
